サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医用画像解析ソフトウェアの世界市場：タイプ別、モダリティ別、アプリケーション別、エンドユーザー別：機会分析と産業予測、2022-2031年
市場調査レポート
商品コード
1266400

医用画像解析ソフトウェアの世界市場：タイプ別、モダリティ別、アプリケーション別、エンドユーザー別：機会分析と産業予測、2022-2031年

Medical Image Analysis Software Market By Type, By Modality, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2022-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 220 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
医用画像解析ソフトウェアの世界市場：タイプ別、モダリティ別、アプリケーション別、エンドユーザー別：機会分析と産業予測、2022-2031年
出版日: 2023年02月01日
発行: Allied Market Research
ページ情報: 英文 220 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医用画像解析ソフトウェア市場は、2021年に39億米ドルと評価され、2022年から2031年にかけて12.2%のCAGRを記録し、2031年には123億米ドルに達すると予測されています。

医用画像解析ソフトウェアのアプリケーションは、PET、MRI、CT、または顕微鏡など、多数のモダリティの医用画像の定量的な解析と視覚化を可能にします。3D医用画像の手動および自動解析を可能にするアプリケーションは、医療提供者と患者の利益となるさまざまな機会を解き放ちます。これには、治癒率や生存率を高めるための早期診断を促進する機械学習システム、診断の検証を行うニューラルネットワーク、隠れたパターンと貴重な洞察を発見して医薬品開発を改善するための研究専用アルゴリズムが含まれます。また、複雑な画像の検査や、治療部位をピンポイントで特定し、侵襲的な処置の際に健康な組織へのダメージを最小限に抑える有害症状セグメンテーションソリューション、医療専門家の没入型トレーニングや患者教育、高度診断を可能にする3D画像とバーチャルリアリティ（VR）デバイスを統合したアプリケーションも含まれます。画像解釈のパイプラインに先進技術を組み込むことで、ヘルスケア部門は大量のデータに関連する課題に対処することができます。医療用画像解析ツールのカスタムソフトウェア開発は、このプロセスにおける重要なステップです。

医療用画像解析ソフトウェア市場の成長は、慢性疾患の発生率の増加、高齢化社会における医療サービスの需要の増加、コンピューター支援診断（CAD）などの画像技術分野における継続的な開拓によってもたらされます。さらに、高齢者人口の増加や、慢性疾患の迅速な診断を可能にする超音波画像診断システムの採用が進んでいることも、市場拡大に大きく寄与すると予想されます。さらに、医用画像解析ソフトウェアの世界市場の成長は、医用画像解析ソフトウェアの進歩の増加などの要因によって大きく牽引され、市場の成長につながると期待されています。世界の医療用画像解析ソフトウェア市場の著名なプレーヤーは、市場での地位を強化し、競争環境を維持するために、製品の発売、買収、医療用画像解析ソフトウェアの進歩のための研究開発への投資など、さまざまな戦略を選択しています。

医療用画像解析ソフトウェア製品の利点に関する認知度の大幅な向上、医療用画像解析におけるソフトウェアの使用率の上昇、病気に苦しむ患者数の急増などが、市場の成長を促進する主な要因となっています。しかし、保存されるデータのセキュリティリスクや、高い導入コストとメンテナンスが市場成長の妨げとなっています。逆に、医療用画像処理における人工知能（AI）の導入は、市場成長のための有利な機会を提供すると期待される予測期間において、市場のダイナミクスを変化させています。医療用画像処理分野における広範な研究開発活動は、医療インフラの大幅な改善とともに、市場拡大のための新たな道を開くと予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • トップインパクトファクター
    • トップインベストメントポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • ライバルの強さ
  • 市場力学
    • 促進要因
      • 慢性疾患の有病率の増加
      • 画像処理技術分野における開発の高まり
      • 医療分野での利用が増加
    • 抑制要因
      • 保存されるデータの高いセキュリティリスク
    • 機会
      • 医用画像診断における人工知能（AI）の導入について
  • COVID-19市場への影響度分析

第4章 医用画像解析ソフトウエア市場：タイプ別

  • 概要
    • 市場規模・予測
  • 統合
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • スタンドアローン
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第5章 医用画像解析ソフトウェア市場：様式別（MODALITY別

  • 概要
    • 市場規模・予測
  • コンピュータ断層撮影
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 磁気共鳴イメージング
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 超音波
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 複合的なモダリティ
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第6章 医用画像解析ソフトウェア市場：用途別

  • 概要
    • 市場規模・予測
  • オーソペディック
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • デンタル
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 神経学
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 循環器内科
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • オンコロジー
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第7章 医用画像解析ソフトウエア市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 診断センター
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第8章 医用画像解析ソフトウエア市場：地域別

  • 概要
    • 市場規模・予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模・予測：タイプ別
    • 市場規模・予測：モダリティ別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 米国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • カナダ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • メキシコ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模・予測：タイプ別
    • 市場規模・予測：モダリティ別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ドイツ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • フランス
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 英国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • イタリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • スペイン
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他欧州
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • アジア太平洋地域
    • 主な動向と機会
    • 市場規模・予測：タイプ別
    • 市場規模・予測：モダリティ別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 中国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 日本
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • インド
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • オーストラリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 韓国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • LAMEA
    • 主な動向と機会
    • 市場規模・予測：タイプ別
    • 市場規模・予測：モダリティ別
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ブラジル
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • サウジアラビア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 南アフリカ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • LAMEAの残りの地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：タイプ別
      • 市場規模・予測：モダリティ別
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別

第9章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第10章 企業プロファイル

  • Agfa Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Coexya
  • ESAOTE SPA
  • GE Healthcare
  • IBM Corporation
  • Koninklijke Philips N.V.
  • MIM Software, Inc
  • Siemens Healthineers
  • Spacelabs Healthcare
図表

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 02. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 05. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 11. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 29. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 33. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 44. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 54. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 57. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 58. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 62. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 66. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 67. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 70. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 71. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 73. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 75. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 79. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 83. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 91. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 102. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 105. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 108. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 109. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 111. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 112. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 113. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 115. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 116. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 117. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 118. AGFA HEALTHCARE: KEY EXECUTIVES
  • TABLE 119. AGFA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 120. AGFA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 121. AGFA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 122. AGFA HEALTHCARE: KEY STRATERGIES
  • TABLE 123. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 124. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT SEGMENTS
  • TABLE 126. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATERGIES
  • TABLE 128. COEXYA: KEY EXECUTIVES
  • TABLE 129. COEXYA: COMPANY SNAPSHOT
  • TABLE 130. COEXYA: PRODUCT SEGMENTS
  • TABLE 131. COEXYA: PRODUCT PORTFOLIO
  • TABLE 132. COEXYA: KEY STRATERGIES
  • TABLE 133. ESAOTE SPA : KEY EXECUTIVES
  • TABLE 134. ESAOTE SPA : COMPANY SNAPSHOT
  • TABLE 135. ESAOTE SPA : PRODUCT SEGMENTS
  • TABLE 136. ESAOTE SPA : PRODUCT PORTFOLIO
  • TABLE 137. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 138. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 139. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 140. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 141. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 142. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 143. IBM CORPORATION: SERVICE SEGMENTS
  • TABLE 144. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 145. KONINKLIJKE PHILIPS N.V. : KEY EXECUTIVES
  • TABLE 146. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT
  • TABLE 147. KONINKLIJKE PHILIPS N.V. : SERVICE SEGMENTS
  • TABLE 148. KONINKLIJKE PHILIPS N.V. : PRODUCT PORTFOLIO
  • TABLE 149. MIM SOFTWARE, INC: KEY EXECUTIVES
  • TABLE 150. MIM SOFTWARE, INC: COMPANY SNAPSHOT
  • TABLE 151. MIM SOFTWARE, INC: PRODUCT SEGMENTS
  • TABLE 152. MIM SOFTWARE, INC: PRODUCT PORTFOLIO
  • TABLE 153. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 154. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 155. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
  • TABLE 156. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 157. SIEMENS HEALTHINEERS: KEY STRATERGIES
  • TABLE 158. SPACELABS HEALTHCARE: KEY EXECUTIVES
  • TABLE 159. SPACELABS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 160. SPACELABS HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 161. SPACELABS HEALTHCARE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 10. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 26. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 30. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY REGION, 2021
  • FIGURE 31. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2021
  • FIGURE 57. AGFA HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 58. AGFA HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. AGFA HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. GE HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. GE HEALTHCARE: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 65. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 66. GE HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 67. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 69. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 70. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. KONINKLIJKE PHILIPS N.V. : NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 72. KONINKLIJKE PHILIPS N.V. : RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 73. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 75. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 76. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 77. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A11265

The medical image analysis software market was valued at $3.9 billion in 2021 and is projected to reach $12.3 billion by 2031, registering a CAGR of 12.2% from 2022 to 2031.  

The application of medical image analysis software enables quantitative analysis and visualization of medical images of numerous modalities such as PET, MRI, CT, or microscopy. The applications of enabling both manual and automated analysis of 3D medical images unlocks various opportunities to the benefit of providers and patients. It includes machine learning systems to facilitate early diagnostics for higher cure and survival rates, neural networks for diagnosis validation, research-specific algorithms to find hidden patterns and valuable insights to improve drug development. It may also include the examination of complex imaging types with adverse symptoms segmentation solutions to pinpoint a treatment area and thus minimizing possible damage to healthy tissue during an invasive procedure, applications integrating 3D imaging with virtual reality (VR) devices to enable immersive training of health specialists, patient education, and advanced diagnostics. Integrating advanced technologies into the image interpretation pipeline can help the healthcare sector address challenges associated with large amounts of data. Custom software development of medical image analysis tools is a critical step in this process. 

The growth of the medical image analysis software market is driven by increasing incidence of chronic diseases, rise in demand for health care services for the aging population, and continuous developments in the field of imaging technology, such as computer-aided diagnosis (CAD). Moreover, the rise in the geriatric population and growing adoption of ultrasound imaging systems to facilitate faster diagnosis of chronic diseases is expected to notably contribute toward the market growth. Furthermore, the global medical image analysis software market growth is largely driven by factors such as an increase in advancements of medical imaging software which is expected to lead to the growth of the market. Prominent players in the global medical image analysis software market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in medical image analysis software to strengthen their position in the market and sustain the competitive environment.  

A significant increase in awareness about the advantages of medical imaging software products, rise in the usage of software in medical imaging, and surge in the number of patients suffering from diseases are some of the key factors driving the growth of the market. However, the security risks of data stored concerns and high installation cost and maintenance hamper the market growth. Conversely, introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in the forecast period which is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical imaging along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market. 

The global medical image analysis software market is segmented based on type, modality, imaging type, application, end user, and region. On the basis of type, the market is classified into integrated and standalone. As per modalities, the market is classified into tomography, ultrasound imaging, radiographic imaging, and combined modalities. According to imaging type, the market is classified into 2D imaging, 3D imaging, and 4D imaging. Depending on application, the market is classified into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, and others. By end user, the market is classified into hospitals, diagnostic centers, ambulatory surgical centers, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include: Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Spacelabs Healthcare, Agfa-Gevaert Group, MIM Software, Inc., Toshiba Medical Systems Corporation, ESAOTE SPA, Merge Healthcare, Inc., and Aquilab SAS. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical image analysis software market analysis from 2021 to 2031 to identify the prevailing medical image analysis software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical image analysis software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical image analysis software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Integrated
  • Stand-alone

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Combined Modalities
  • Others

By Application

  • Orthopedic
  • Dental
  • Neurology
  • Cardiology
  • Oncology
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • IBM Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • Siemens Healthineers
  • ESAOTE SPA 
  • Coexya
  • MIM Software, Inc
  • Koninklijke Philips N.V. 
  • GE Healthcare
  • Spacelabs Healthcare
  • Agfa Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of chronic diseases
      • 3.4.1.2. Rise in developments in the field of imaging technology
      • 3.4.1.3. Increase in usage in medical applications
    • 3.4.2. Restraints
      • 3.4.2.1. High security risks of data stored
    • 3.4.3. Opportunities
      • 3.4.3.1. Introduction of Artificial Intelligence (AI) in medical imaging
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Integrated
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Stand-alone
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Computed Tomography
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Magnetic Resonance Imaging
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Ultrasound
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Combined Modalities
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Orthopedic
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dental
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Neurology
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Cardiology
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Oncology
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country
  • 6.7. Others
    • 6.7.1. Key market trends, growth factors and opportunities
    • 6.7.2. Market size and forecast, by region
    • 6.7.3. Market share analysis by country

CHAPTER 7: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Diagnostic Centers
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Modality
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Modality
      • 8.2.6.1.4. Market size and forecast, by Application
      • 8.2.6.1.5. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Modality
      • 8.2.6.2.4. Market size and forecast, by Application
      • 8.2.6.2.5. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Modality
      • 8.2.6.3.4. Market size and forecast, by Application
      • 8.2.6.3.5. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Modality
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Modality
      • 8.3.6.1.4. Market size and forecast, by Application
      • 8.3.6.1.5. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Modality
      • 8.3.6.2.4. Market size and forecast, by Application
      • 8.3.6.2.5. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Modality
      • 8.3.6.3.4. Market size and forecast, by Application
      • 8.3.6.3.5. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Modality
      • 8.3.6.4.4. Market size and forecast, by Application
      • 8.3.6.4.5. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Modality
      • 8.3.6.5.4. Market size and forecast, by Application
      • 8.3.6.5.5. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Modality
      • 8.3.6.6.4. Market size and forecast, by Application
      • 8.3.6.6.5. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Modality
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. China
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Modality
      • 8.4.6.1.4. Market size and forecast, by Application
      • 8.4.6.1.5. Market size and forecast, by End User
      • 8.4.6.2. Japan
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Modality
      • 8.4.6.2.4. Market size and forecast, by Application
      • 8.4.6.2.5. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Modality
      • 8.4.6.3.4. Market size and forecast, by Application
      • 8.4.6.3.5. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Modality
      • 8.4.6.4.4. Market size and forecast, by Application
      • 8.4.6.4.5. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Modality
      • 8.4.6.5.4. Market size and forecast, by Application
      • 8.4.6.5.5. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Modality
      • 8.4.6.6.4. Market size and forecast, by Application
      • 8.4.6.6.5. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Modality
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Modality
      • 8.5.6.1.4. Market size and forecast, by Application
      • 8.5.6.1.5. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Modality
      • 8.5.6.2.4. Market size and forecast, by Application
      • 8.5.6.2.5. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Modality
      • 8.5.6.3.4. Market size and forecast, by Application
      • 8.5.6.3.5. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Modality
      • 8.5.6.4.4. Market size and forecast, by Application
      • 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agfa Healthcare
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. CANON MEDICAL SYSTEMS CORPORATION
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Coexya
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. ESAOTE SPA 
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
  • 10.5. GE Healthcare
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
  • 10.6. IBM Corporation
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
  • 10.7. Koninklijke Philips N.V. 
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
  • 10.8. MIM Software, Inc
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Siemens Healthineers
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Spacelabs Healthcare
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio